GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3751 - 3775 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgA Patient 3 -180 mild
G68461PT
2157
IgA Patient 3 11 mild
G76615YG
2157
IgA Patient 3 -180 mild
G82204SH
2176
IgM Patient 2 15 mild
G76355TG
2231
IgM Patient 4 12 mild
G14844CX
2240
IgA Patient 2 3 mild
G42666HT
2242
IgA Patient 2 15 mild
G35446HX
2247
IgG Patient 3 11 mild
G12200GB
2256
IgG Patient 3 4 mild
G60761LT
2268
IgG Patient 3 -180 mild
G08340FW
2275
IgG Patient 3 11 mild
G68461PT
2303
IgG Patient 1 6 moderate
G90562PB
2317
IgA Patient 3 -180 mild
G14569AR
2329
IgG Patient 3 4 mild
G64669AQ
2347
IgA Patient 3 4 mild
G17689EW
2358
IgA Patient 3 4 mild
G76615YG
2367
IgA Patient 4 12 mild
G25559RS
2374
IgA Patient 3 -180 mild
G11460AB
2380
IgA Patient 3 -180 mild
G37036SF
2400
IgG Patient 2 15 mild
G62826CL
2402
IgM Patient 2 24 mild
G76355TG
2417
IgM Patient 2 24 mild
G15407YE
2426
IgG Patient 3 11 mild
G24617OK
2427
IgA Patient 3 11 mild
G68461PT
2440
IgA Patient 3 4 mild
G37036SF
2451

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024